Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; FDA Recall Regulations, 27694 [2015-11624]
Download as PDF
<![CDATA[
27694
Federal Register / Vol. 80, No. 93 / Thursday, May 14, 2015 / Notices
TABLE 1—ESTIMATED REPORTING BURDEN 1—Continued
Surveys of pharmacists and patients on variations in the
physical characteristics of generic drug pills and patients’
perceptions
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
Total annual
responses
Total
Hours
Survey of patients #2 ...........................................................
1,000
1
1,000
0.3
(18 minutes)
300
Total ..............................................................................
........................
........................
........................
........................
1,017
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
is determined prior to mailing the surveys; screening is not required.
2 Eligibility
References
On
February 27, 2015, the Agency
submitted a proposed collection of
information entitled, ‘‘FDA Recall
Regulations’’ to OMB for review and
clearance under 44 U.S.C. 3507. An
Agency may not conduct or sponsor,
and a person is not required to respond
to, a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0249. The
approval expires on March 31, 2018. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
SUPPLEMENTARY INFORMATION:
The following references have been
placed on display in the Division of
Dockets Management (see ADDRESSES)
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday, and are available
electronically at https://
www.regulations.gov.
1. Woodward, C.A., ‘‘Questionnaire
Construction and Question Writing for
Research in Medical Education,’’
Medical Education, 22, pp. 345–363
(1988).
2. Fitzpatrick, R., ‘‘Surveys of Patient
Satisfaction: II—Designing a
Questionnaire and Conducting a
Survey,’’ British Medical Journal,
302(6785), pp. 1129–1132 (1991).
Dated: May 8, 2015.
Leslie Kux,
Associate Commissioner for Policy.
Dated: May 8, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–11624 Filed 5–13–15; 8:45 am]
[FR Doc. 2015–11623 Filed 5–13–15; 8:45 am]
BILLING CODE 4164–01–P
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food and Drug Administration
[Docket No. FDA–2014–N–1076]
[Docket No. FDA–2014–N–1031]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Guidance for Industry: Formal Dispute
Resolution; Scientific and Technical
Issues Related to Pharmaceutical
Current Good Manufacturing Practice
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
FDA Recall Regulations
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
AGENCY:
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled,
‘‘FDA Recall Regulations’’ has been
approved by the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:59 May 13, 2015
Jkt 235001
ACTION:
Food and Drug Administration,
Notice.
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled,
‘‘Guidance for Industry: Formal Dispute
Resolution; Scientific and Technical
Issues Related to Pharmaceutical
Current Good Manufacturing Practice’’
has been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
SUMMARY:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Dated: May 8, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–11609 Filed 5–13–15; 8:45 am]
BILLING CODE 4164–01–P
HHS.
Notice.
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: On
January 8, 2015, the Agency submitted
a proposed collection of information
entitled, ‘‘Guidance for Industry: Formal
Dispute Resolution; Scientific and
Technical Issues Related to
Pharmaceutical Current Good
Manufacturing Practice’’ to OMB for
review and clearance under 44 U.S.C.
3507. An Agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number. OMB has now
approved the information collection and
has assigned OMB control number
0910–0563. The approval expires on
April 30, 2018. A copy of the supporting
statement for this information collection
is available on the Internet at https://
www.reginfo.gov/public/do/PRAMain.
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[Docket No. USCBP–2015–0020]
The U.S. Customs and Border
Protection Airport and Seaport
Inspections User Fee Advisory
Committee (UFAC)
U.S. Customs and Border
Protection, Department of Homeland
Security (DHS).
ACTION: Committee Management; Notice
of Federal Advisory Public Committee
Meeting.
AGENCY:
The U.S. Customs and Border
Protection Airport and Seaport
Inspections User Fee Advisory
Committee (UFAC) will meet on
Tuesday, June 2, 2015, in Washington,
SUMMARY:
E:\FR\FM\14MYN1.SGM
14MYN1
]]>Agencies
[Federal Register Volume 80, Number 93 (Thursday, May 14, 2015)]
[Notices]
[Page 27694]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-11624]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-1031]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; FDA Recall Regulations
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled, ``FDA Recall Regulations'' has been
approved by the Office of Management and Budget (OMB) under the
Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: On February 27, 2015, the Agency submitted a
proposed collection of information entitled, ``FDA Recall Regulations''
to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not
conduct or sponsor, and a person is not required to respond to, a
collection of information unless it displays a currently valid OMB
control number. OMB has now approved the information collection and has
assigned OMB control number 0910-0249. The approval expires on March
31, 2018. A copy of the supporting statement for this information
collection is available on the Internet at https://www.reginfo.gov/public/do/PRAMain.
Dated: May 8, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-11624 Filed 5-13-15; 8:45 am]
BILLING CODE 4164-01-P
